| Download ( PDF | 505kB) |
Interferon-gamma is required in activation of macrophages for tumor cytotoxicity
Männel, Daniela N. und Falk, Werner (1983) Interferon-gamma is required in activation of macrophages for tumor cytotoxicity. Cellular immunology 79 (2), S. 396-402.Veröffentlichungsdatum dieses Volltextes: 21 Jul 2010 05:06
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.15972
Zusammenfassung
The participation of interferon-gamma in activation of murine macrophages for tumor cell lysis was investigated. Biochemically macrophage activation factor and interferon-gamma have not been separated. Antiviral titers correlated closely with macrophage activation in antigen- or mitogen-induced spleen cell supernatants. A monoclonal rat antibody that neutralized virus-induced interferon was also ...
The participation of interferon-gamma in activation of murine macrophages for tumor cell lysis was investigated. Biochemically macrophage activation factor and interferon-gamma have not been separated. Antiviral titers correlated closely with macrophage activation in antigen- or mitogen-induced spleen cell supernatants. A monoclonal rat antibody that neutralized virus-induced interferon was also found to neutralize interferon-gamma in such supernatants. These monoclonal antibodies were coupled to CH-Sepharose 4B and used for absorption of antiviral activity from mitogen-induced spleen cell supernatants. Absorption of the interferon was paralleled by the reduction of the macrophage-activating capacity of the supernatants. Data from control absorptions supported the specificity of the absorption effect. These results indicate that interferon-gamma is required for activation of macrophages for tumor cell lysis. These results can be interpreted in two ways: (a) the monoclonal antibodies cross-react with interferon-gamma and with a mediator that is required for activation of macrophages for tumor cell lysis or (b) interferon-gamma itself is an essential cofactor for macrophage activation.
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||||||||||||||||||||||||||||||||||||
| Titel eines Journals oder einer Zeitschrift | Cellular immunology | ||||||||||||||||||||||||||||||||||||||
| Verlag: | Elsevier | ||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Band: | 79 | ||||||||||||||||||||||||||||||||||||||
| Nummer des Zeitschriftenheftes oder des Kapitels: | 2 | ||||||||||||||||||||||||||||||||||||||
| Seitenbereich: | S. 396-402 | ||||||||||||||||||||||||||||||||||||||
| Datum | 1983 | ||||||||||||||||||||||||||||||||||||||
| Institutionen | Medizin > Lehrstuhl für Innere Medizin I Medizin > Lehrstuhl für Immunologie | ||||||||||||||||||||||||||||||||||||||
| Identifikationsnummer |
| ||||||||||||||||||||||||||||||||||||||
| Klassifikation |
| ||||||||||||||||||||||||||||||||||||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin | ||||||||||||||||||||||||||||||||||||||
| Status | Veröffentlicht | ||||||||||||||||||||||||||||||||||||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||||||||||||||||||||||||||||||||||||
| An der Universität Regensburg entstanden | Unbekannt / Keine Angabe | ||||||||||||||||||||||||||||||||||||||
| URN der UB Regensburg | urn:nbn:de:bvb:355-epub-159727 | ||||||||||||||||||||||||||||||||||||||
| Dokumenten-ID | 15972 |
Downloadstatistik
Downloadstatistik